The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Oncology Drug Shortages Persist, but Continue to Evolve
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
4.
Renewing the call for a national Cancer Patient's Bill of Rights
5.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
1.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
2.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
3.
The Rise of Immunotherapy: New Advances in Cancer Treatment
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
Introduction to Immune Thrombocytopenic Purpura
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation